Wen Lai Zhou

Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China.

Beijing Danqin Pharma Technology Co., Ltd. is an innovative drug research and development company that focuses on precision targeting tumor targets in the 2.0 era. The company was founded in 2021 and is based in Beijing, China. The Chinese company's goal is to develop drugs that meet patients' clinical needs and promote medical innovation. The company's new pharmaceutical projects in the world's first (FIC) drug projects are under research, with scientific research platforms such as drug design, chemical synthesis, pharmacological research, pharmacological metabolism and security evaluation, drug analysis, patent, and registration. The company was founded by Wen Lai Zhou, Hong Mei Li, Dan Yan, Jin Cong Zhuo, and Wen Lai Zhou has been the CEO since incorporation.

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD.